S&P 500
7,588.60
+0.51%
Dow Jones
52,758.90
+0.47%
Nasdaq 100
29,885.70
+0.46%
Russell 2000
2,982.51
-0.27%
FTSE 100
10,543.60
+0.61%
Nikkei 225
69,317.20
+0.42%

Investing

First Look Analysts Research Calls for Friday, February 24

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
First Look Analysts Research Calls for Friday, February 24

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Century Aluminum (CENX) upgraded to Peer Perform from Underperform at Wolfe Research

> Esperion Therapeutics (ESPR) upgraded to Buy from Hold at Jefferies; tgt $12

> Grainger (GWW) upgraded to Sector Perform from Underperform at RBC Capital Mkts; tgt raised to $679

> LyondellBasell (LYB) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $130

> NeoGenomics (NEO) upgraded to Buy from Hold at The Benchmark Company; tgt $20

> Youdao (DAO) upgraded to Buy from Hold at Jefferies; tgt raised to $10

Downgrades:

> C4 Therapeutics (CCCC) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $5

> CURO Group (CURO) downgraded to Underperform from Neutral at Credit Suisse; tgt lowered to $4

> Moderna (MRNA) downgraded to Underperform from Market Perform at SVB Securities; tgt lowered to $93

> Nektar Therapeutics (NKTR) downgraded to Underperform from Hold at Jefferies; tgt lowered to $1.50

> New York Mortgage Trust (NYMT) downgraded to Neutral from Buy at Ladenburg Thalmann

> OGE Energy (OGE) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $39

Others:

> Biomea Fusion (BMEA) initiated with a Buy at Citigroup; tgt $20

> Erasca (ERAS) initiated with a Buy at Goldman; tgt $10

> KE Holdings (BEKE) initiated with a Buy at Daiwa Securities

Contact [email protected] for any questions or corrections.

Disclaimer: Energy Exploration Technologies, Inc. ("EnergyX") has engaged 24/7 Wall St to publish this communication in connection with EnergyX's ongoing Regulation A offering. 24/7 Wall St has been paid in cash and may receive additional compensation. 24/7 Wall St and/or its affiliates do not currently hold securities of EnergyX.

This compensation and any current or future ownership interest could create a conflict of interest. Please consider this disclosure alongside EnergyX's offering materials. EnergyX's Regulation A offering has been qualified by the SEC. Offers and sales may be made only by means of the qualified offering circular. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at invest.energyx.com/.

Comparisons to other companies are for informational purposes only and should not imply similar results. Past performance is not indicative of future results. Market shortfall are forward‑looking estimates and are subject to substantial uncertainty. Investments in private placements, and start-up investments in particular, are long-term, illiquid, speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups

Follow 24/7 Wall St. on Google
Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Opening Bell Analysts Research Calls for Tuesday, January 3
Paul Ausick |

Opening Bell Analysts Research Calls for Tuesday, January 3

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.  Upgrades: >…

First Look Analyst Calls Briefing for Tuesday, November 1, 2022 
Paul Ausick |

First Look Analyst Calls Briefing for Tuesday, November 1, 2022 

Here is a list of analysts' research calls made early Tuesday morning.

First Look Analysts Research Calls for Friday, February 3
Paul Ausick |

First Look Analysts Research Calls for Friday, February 3

This report was sent to Briefing.com subscribers earlier today.  Upgrades: > Cardinal Health (CAH) upgraded to Outperform from Neutral at…

First Look Analysts Research Calls for Tuesday, January 3
Paul Ausick |

First Look Analysts Research Calls for Tuesday, January 3

This report was sent to Briefing.com subscribers earlier today.  Upgrades: > Adaptimmune Therapeutics (ADAP) upgraded to Buy from Neutral at…

Morning Analyst Calls Briefing for Tuesday, November 8, 2022 
Paul Ausick |

Morning Analyst Calls Briefing for Tuesday, November 8, 2022 

Here is a second list of analysts' research calls released Tuesday morning.

Opening Bell Analysts Research Calls for Monday, February 27
Paul Ausick |

Opening Bell Analysts Research Calls for Monday, February 27

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here. Upgrades: >…

Opening Bell Analysts Research Calls for Tuesday, March 7
Paul Ausick |

Opening Bell Analysts Research Calls for Tuesday, March 7

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.  Upgrades: >…

Opening Bell Analysts Research Calls for Friday, January 20
Paul Ausick |

Opening Bell Analysts Research Calls for Friday, January 20

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.   Upgrades:…

Opening Bell Analysts Research Calls for Monday, January 9
Paul Ausick |

Opening Bell Analysts Research Calls for Monday, January 9

This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.   Upgrades:…

Top Gaining Stocks

Meta
META • Vol: 40,760,422
CarMax
KMX • Vol: 2,288,021
Weyerhaeuser
WY • Vol: 6,523,553
SBA Communications
SBAC • Vol: 1,443,801
NVIDIA
NVDA • Vol: 148,249,982

Top Losing Stocks

Moderna
MRNA • Vol: 9,176,778
Coterra Energy
CTRA • Vol: 73,319,495
CrowdStrike
CRWD • Vol: 9,269,567
Datadog
DDOG • Vol: 5,135,556
EPAM Systems
EPAM • Vol: 1,164,561